Clinical Trials Browser

INDUSTRY × Lung Neoplasms × sargramostim × Clear all

NCT01789099 2024-12-16

UV1-hTERT2012L

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01909752 2017-07-06

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms